A post-doctoral position is available:
Imaging biomarkers for TMS treatment of depression
is part of the University of Michigan Health System, one of the nation's leading health care facilities, and is home to the nation's first comprehensive Depression Center and the Molecular and Behavioral Neurosciences Institute.
We provide patients with state-of-the-art treatment and care of psychiatric disorders, much of it based on the innovative research done by our faculty. Our psychiatric care facility is one of the best in the country, and was one of the very first to provide modern diagnosis and research on mental disorders.
On this site you will find information about our physicians and caregivers, clinical specialities and programs, research programs, and educational opportunities.
An alternative treatment for depression
TMS is a relatively new, FDA-approved treatment for depression that works by stimulating a part of the brain that regulates mood. TMS is completely non-invasive and has been proven safe and effective for reducing the symptoms of depression in adults who have not improved with traditional treatments, including medication or psychotherapy. This treatment is offered through our outpatient psychiatry services
Risk of depression influenced by quality of relationships
After analyzing data from nearly 5,000 American adults, the researchers found that the quality of a personís relationships with a spouse, family and friends predicted the likelihood of major depression disorder in the future, regardless of how frequently their social interactions took place.
© 2003-2013 Regents of the University of Michigan
The University of Michigan Department of Psychiatry web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site. Complete disclaimer and Privacy Statement.